Option Care Health, Inc. (OPCH)

Market Cap	5.10B
Revenue (ttm)	5.19B
Net Income (ttm)	213.77M
Shares Out	163.75M
EPS (ttm)	1.25
PE Ratio	24.89
Forward PE	22.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	668,228
Open	31.32
Previous Close	31.03
Day's Range	30.85 - 31.36
52-Week Range	21.39 - 35.53
Beta	0.73
Analysts	Strong Buy
Price Target	35.86 (+15.08%)
Earnings Date	Jul 30, 2025

About OPCH

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic art...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: John Rademacher
• Employees: 8,088
• Stock Exchange: NASDAQ
• Ticker Symbol: OPCH
• Website: https://www.optioncarehealth.com

Financial Performance

In 2024, Option Care Health's revenue was $5.00 billion, an increase of 16.17% compared to the previous year's $4.30 billion. Earnings were $211.82 million, a decrease of -20.69%.

Analyst Summary

According to 7 analysts, the average rating for OPCH stock is "Strong Buy." The 12-month stock price target is $35.86, which is an increase of 15.08% from the latest price.

Price Target

$35.86

(15.08% upside)

Analyst Consensus: Strong Buy